Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Feb 28;12(5):1899.
doi: 10.3390/jcm12051899.

Role of Phytotherapy in the Management of BPH: A Summary of the Literature

Vaki Antoniou  1 , Vineet Gauhar  2 , Sachin Modi  3 , Bhaskar Kumar Somani  1
Affiliations
Review

Role of Phytotherapy in the Management of BPH: A Summary of the Literature

Vaki Antoniou et al. J Clin Med. .

Abstract

Benign prostatic hyperplasia (BPH) describes the non-malignant enlargement of the prostate. It is both common and growing in incidence. Treatment is multimodal, involving conservative, medical, and surgical interventions. This review aims to examine the evidence base for phytotherapies, specifically analyzing their role in treating lower urinary tract symptoms (LUTS) attributable to BPH. A literature search was completed, specifically looking for randomized control trials (RCTs) and systematic reviews involving phytotherapy treating BPH. Specific emphasis was placed on exploring substance origin, the proposed mechanism of action, evidence of efficacy, and the side-effect profile. Several phytotherapeutic agents were evaluated. These included serenoa repens, cucurbita pepo, and pygeum Africanum, among others. For most of the reviewed substances, only modest effectiveness was reported. Generally, though, all treatments were tolerated well with minimal side effects. None of the treatments discussed in this paper form part of the recommended treatment algorithm in either European or American guidelines. We, therefore, conclude that phytotherapies, in the treatment of LUTS attributable to BPH, do provide a convenient option for patients, with minimal side effects. At present, however, the evidence for the usage of phytotherapy in BPH is inconclusive, with some agents having more backing than others. This remains an expansive field of urology whereby there is still more research to be done.

Keywords: BPH; LUTS; phytotherapy; prostate.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Awedew A.F., Han H., Abbasi B., Abbasi-Kangevari M., Ahmed M.B., Almidani O., Amini E., Arabloo J., Argaw A.M., Athari S.S., et al. The global, regional, and national burden of benign prostatic hyperplasia in 204 countries and territories from 2000 to 2019: A systematic analysis for the Global Burden of Disease Study 2019. Lancet Heal. Longev. 2022;3:e754–e776. doi: 10.1016/S2666-7568(22)00213-6. - DOI - PMC - PubMed
    1. Lowe F.C., Ku J.C. Phytotherapy in treatment of benign prostatic hyperplasia: A critical review. Urology. 1996;48:12–20. doi: 10.1016/S0090-4295(96)00077-5. - DOI - PubMed
    1. Weisser H., Tunn S., Behnke B., Krieg M. Effects of the Sabal serrulata extract IDS 89 and its subfractions on 5α-reductase activity in human benign prostatic hyperplasia. Prostate. 1996;28:300–306. doi: 10.1002/(SICI)1097-0045(199605)28:5<300::AID-PROS5>3.0.CO;2-F. - DOI - PubMed
    1. Comhaire F., Mahmoud A. Preventing diseases of the prostate in the elderly using hormones and nutriceuticals. Aging Male. 2004;7:155–169. doi: 10.1080/13685530412331284722. - DOI - PubMed
    1. Gravas S., Samarinas M., Zacharouli K., Karatzas A., Tzortzis V., Koukoulis G., Melekos M. The effect of hexanic extract of Serenoa Repens on prostatic inflammation: Results from a randomized biopsy study. World J. Urol. 2018;37:539–544. doi: 10.1007/s00345-018-2409-1. - DOI - PubMed

LinkOut - more resources